Template:Nicardipine

style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";

! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | Nicardipine |- ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CARDENE I.V.^® FDA Package Insert |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Indications and Usage |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Dosage and Administration |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Dosage Forms and Strengths |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Contraindications |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Warnings and Precautions |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Adverse Reactions |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Drug Interactions |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Use in Specific Populations |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Overdosage |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Description |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Clinical Pharmacology |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Nonclinical Toxicology |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Clinical Studies |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | How Supplied/Storage and Handling |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Patient Counseling Information |- ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CARDENE SR ^® FDA Package Insert

|- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Indications and Usage |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Dosage and Administration |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Dosage Forms and Strengths |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Contraindications |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Warnings and Precautions |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Adverse Reactions |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Drug Interactions |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Use in Specific Populations |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Overdosage |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Description |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Clinical Pharmacology |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Nonclinical Toxicology |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Clinical Studies |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | How Supplied/Storage and Handling |- ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | Patient Counseling Information |-